학술논문
Efficacy and Safety of Ramucirumab With Docetaxel Versus Placebo With Docetaxel as Second-Line Treatment of Advanced Non–Small-Cell Lung Cancer: A Subgroup Analysis According to Patient Age in the REVEL Trial
Document Type
Article
Author
Ramalingam, Suresh S.; Pérol, Maurice; Reck, Martin; Kowalyszyn, Ruben Dario; Gautschi, Oliver; Kimmich, Martin; Cho, Eun Kyung; Czyzewicz, Grzegorz; Grigorescu, Alexandru; Karaseva, Nina; Dakhil, Shaker; Lee, Pablo; Zimmerman, Annamaria; Sashegyi, Andreas; Alexandris, Ekaterine; Carter, Gebra Cuyun; Winfree, Katherine B.; Garon, Edward B.
Source
In Clinical Lung Cancer May 2018 19(3):270-279
Subject
Language
ISSN
1525-7304